XML 48 R38.htm IDEA: XBRL DOCUMENT v3.25.2
INVESTMENTS – RELATED PARTIES (Tables)
 6 Months Ended
Jun. 30, 2025
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]  
Schedule of investment
                  
   Interest      June 30,   December 31, 
   Rate   Due Date  2025   2024 
Promissory note and accrued interest receivable, Ault & Company, in default   8%  December 31, 2024  $541,000   $2,468,000 
Promissory note and accrued interest receivable, GIGA   6% - 12%   In bankruptcy   20,320,000    18,499,000 
Other           335,000    335,000 
Allowance for credit losses           (500,000)   (500,000)
Total investment in promissory notes and other, related parties            $20,696,000   $20,802,000 
Schedule of Interest income, related party
        
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2025   2024   2025   2024 
Interest income, related party  $570,000   $269,000   $1,148,000   $478,000 
Schedule of investment in common stock
               
   Investments in Common Stock, Related Parties at June 30, 2025 
   Cost   Gross Unrealized Losses   Fair value 
Common shares  $24,331,000   $(24,307,000)  $24,000 
Alzamend series B convertible preferred stock, warrants   2,100,000    -    2,100,000 
   $26,431,000   $(24,307,000)  $2,124,000 

 

   Investments in Common Stock, Related Parties at December 31, 2024 
   Cost   Gross Unrealized Losses   Fair value 
Common shares  $24,697,000   $(24,607,000)  $90,000 
Alzamend series B convertible preferred stock, warrants   2,100,000    -    2,100,000 
   $26,797,000   $(24,607,000)  $2,190,000 
Schedule of investment in warrants and common stock
          
   For the Three Months Ended June 30, 
   2025   2024 
Balance at April 1  $81,000   $768,000 
Investment in common stock of Alzamend   -    3,000 
Sale of Alzamend common stock   (6,000)   - 
Realized loss in common stock of Alzamend   (368,000)   - 
Unrealized gain (loss) in common stock of Alzamend   317,000    (467,000)
Balance at June 30  $24,000   $304,000 

 

The following tables summarize the changes in the Company’s investments in Alzamend common stock during the six months ended June 30, 2025 and 2024:

 

   For the Six Months Ended June 30, 
   2025   2024 
Balance at January 1  $90,000   $679,000 
Investment in common stock of Alzamend   8,000    8,000 
Sale of Alzamend common stock   (6,000)   - 
Realized loss in common stock of Alzamend   (368,000)   - 
Unrealized gain (loss) in common stock of Alzamend   300,000    (383,000)
Balance at June 30  $24,000   $304,000 
Schedule of investment in warrants and preferred stock
          
   June 30,   December 31, 
   2025   2024 
Investment in Alzamend preferred stock  $2,100,000   $2,100,000 
Total investment in other investments securities, related party  $2,100,000   $2,100,000